Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 21,031 | 12,827 | 32,682 | 136 | 15,773 |
| Depreciation Amortization | 3,179 | 2,135 | 1,076 | 6,881 | 5,796 |
| Accounts receivable | 1,291 | 1,186 | -693 | -2,068 | N/A |
| Accounts payable and accrued liabilities | -2,402 | -1,887 | -1,966 | -2,940 | 1,222 |
| Other Working Capital | -22,258 | -10,609 | -11,712 | -65,509 | -35,383 |
| Other Operating Activity | 14,986 | 9,969 | 7,523 | -85,109 | -97,135 |
| Operating Cash Flow | $15,827 | $13,621 | $26,910 | $-148,609 | $-109,727 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -223 | -215 | -34 | -380 | -290 |
| Net Acquisitions | N/A | N/A | N/A | 141,272 | 141,272 |
| Other Investing Activity | 0 | 0 | 0 | 1,401 | 1,401 |
| Investing Cash Flow | $-223 | $-215 | $-34 | $142,293 | $142,383 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 13,516 |
| Debt Repayment | N/A | N/A | N/A | -127,905 | -127,905 |
| Common Stock Issued | 1,241 | 1,180 | 1,180 | 24,017 | 22,280 |
| Other Financing Activity | 0 | 0 | 0 | 13,516 | 0 |
| Financing Cash Flow | $1,241 | $1,180 | $1,180 | $-90,372 | $-92,109 |
| Exchange Rate Effect | N/A | N/A | N/A | -1 | N/A |
| Beginning Cash Position | 39,461 | 39,461 | 39,461 | 136,150 | 136,150 |
| End Cash Position | 56,306 | 54,047 | 67,517 | 39,461 | 76,697 |
| Net Cash Flow | $16,845 | $14,586 | $28,056 | $-96,689 | $-59,453 |
| Free Cash Flow | |||||
| Operating Cash Flow | 15,827 | 13,621 | 26,910 | -148,609 | -109,727 |
| Capital Expenditure | -223 | -215 | -34 | -380 | -290 |
| Free Cash Flow | 15,604 | 13,406 | 26,876 | -148,989 | -110,017 |